Dr. Enrique Camacho Jr., D.O. General Practice Medicare: Medicare Enrolled Practice Location: 15301 Warren Shingle Rd, Beale Afb, CA 95903 Phone: 530-634-4730 |
Dr. Paul D Vu, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 15301 Warren Shingle Rd, Beale Afb, CA 95903 Phone: 530-634-4671 |
Dr. Dorian Germain Crawford, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 15301 Warren Shingle Rd, Beale Afb, CA 95903 Phone: 503-634-4988 |
Jennifer Lynn Perugini, MD General Practice Medicare: Medicare Enrolled Practice Location: 15301 Warren Shingle Rd, Beale Afb, CA 95903 Phone: 530-634-2941 |
News Archive
One component of Democrats' health reform plan, comparative effectiveness research, would seek to improve quality and lower medical costs by identifying the most clinically and cost-effective treatments available, but a new study by the Rand Corp. finds the impact of the research may be slow to arrive, BusinessWeek reports.
Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.
Significant differences in plastic surgery referral practices by general surgeons treating newly diagnosed breast cancer patients partially explain the low rates of breast reconstructive surgery in the United States, according to a new study.
Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.
Three top consumer groups are urging Congress to include in health care reform legislation transparency requirements for pharmacy benefit managers (PBMs) participating in any new federally sponsored health plans in a public health care exchange. The Consumer Federation of America (CFA), U.S. Public Interest Research Group (PIRG), and the National Legislative Association on Prescription Drug Prices (NLARx) have sent a joint letter to House Speaker Nancy Pelosi (D-CA) supporting the provision, authored by Rep. Anthony Weiner (D-NY) and included in the House Energy and Commerce Committee's America's Affordable Health Choices Act of 2009 (H.R. 3200).
› Verified 6 days ago